(Press-News.org) Researchers at The Jackson Laboratory have identified a molecule that prevents repair of some cancer cells, providing a potential new "genetic chemotherapy" approach to cancer treatment that could significantly reduce side effects and the development of treatment resistance compared with traditional chemotherapy.
In healthy people, white blood cells called B cells (or B lymphocytes) are a kind of sophisticated tool kit, making antibodies against pathogens or other invaders. In the process of antibody production, B cells turn on the gene known as activation-induced cytidine deaminase (AID), which acts as a sort of molecular scissors that cut the chromosomes within the B cell. This is needed to rearrange pieces of the B-cell chromosomes and produce different "flavors" of antibodies that do different jobs.
But in some cancers this process goes wrong, with AID acting out of control and creating mutations and chromosome rearrangements that make the tumor more aggressive.
Those AID-induced cancers proliferate with help from the cell-repair mechanism known as homologous recombination (HR). Researchers in the laboratory of Associate Professor Kevin Mills, Ph.D., identified a molecule called DIDS (for 4,4'-diisothiocyanatostilbene-2-2'-disulfonic acid) that blocks the DNA repair action in chronic lymphocytic leukemia (CLL), causing the cancer cells to die.
"This treatment affects every cell in the body," Mills says. "But by its mode of action it kills only tumor cells that are expressing AID, yet it is almost entirely harmless to normal, healthy cells."
The research, published in The Journal of Experimental Medicine, is the latest proof of principle for what Mills calls "genetic chemotherapy": using the mechanisms involved in genetic instability in cancer, to cause tumor cell self-destruction.
For the new paper, authors Kristin Lamont, Ph.D., a postdoctoral associate, and Muneer Hasham, Ph.D. an associate research scientist, both in the Mills laboratory, tested DIDS in normal mouse cells, mouse cancer cells, human cancer cell lines and human primary cancers. "We collected 74 different primary patient CLL samples," Lamont says, "and measured AID expression in those samples. We found that about 40 percent of them express AID, and if we treated those with DIDS in vitro, the AID-expressing ones had significantly higher levels of DNA damage and died."
Mills adds, "Demonstrating that this works on primary cancer cells moves us one step closer to eventually testing this in patients." The DIDS treatment approach, Mills adds, also addresses the issues of side effects, a major problem with standard chemotherapy.
"By its selectivity for cancer cells, DIDS reduces the issue of the really nasty side effects associated with chemotherapy treatments," Mills explains.
Moreover, the list of cancers associated with aberrant AID expression is growing, so the treatment approach could apply not only to leukemia but also a range of other cancer types.
Mills' collaborators at Memorial Sloan-Kettering Cancer Center in New York shared their expertise in DNA repair to understand the action of the DIDS molecule. "We hypothesized that the molecule would work as it did," Mills says, "but they helped us to determine exactly why and how it works."
Since the researchers submitted the paper for publication, they have developed a new and better potential treatment molecule. "One of our goals is to design an even better molecule," Mills says. "And we've done that. We now have a new molecule in that same class, that delivers significantly more potency, with just as much selectivity as the original molecule."
Cyteir Therapeutics, Inc. a startup biotechnology company founded by Mills in 2012, continues to pursue development of the new molecule for cancer therapy, while Dr. Mills and his team at Jackson will keep studying the cellular mechanisms, in the hope of finding yet more potential new cancer drugs. Cyteir Therapeutics is now ramping up the R&D efforts necessary to take the genetic chemotherapy treatment to clinical trials, possibly in 2014.
###
This work, which took place in The Jackson Laboratory's NCI-designated Cancer Center, was a collaboration with oncologists at Cancer Care of Maine, part of Eastern Maine Medical Care in Bangor, Maine, and the Maine Center for Cancer Medicine and Maine Medical Center Research Institute, both in Scarborough, Maine.
The Jackson Laboratory is an independent, nonprofit biomedical research institution based in Bar Harbor, Maine, with a facility in Sacramento, Calif., and a new genomic medicine institute in Farmington, Conn. It employs a total staff of more than 1,450. Its mission is to discover precise genomic solutions for disease and empower the global biomedical community in the shared quest to improve human health.
Molecule treats leukemia by preventing cancer cell repair, Jackson Laboratory scientists report
2013-04-17
ELSE PRESS RELEASES FROM THIS DATE:
Navy develops high impact, high integrity polymer for air, sea, and domestic applications
2013-04-17
WASHINGTON--U.S. Naval Research Laboratory Chemistry Division scientists have developed a second generation, cost-effective polyetheretherketone (PEEK)-like phthalonitrile-resin demonstrating superior high temperature and flammability properties for use in numerous marine, aerospace and domestic applications.
The resin can be used to make composite components by established industrial methods such as resin transfer molding (RTM), resin infusion molding (RIM), filament winding, prepreg consolidation, and potentially by automated composite manufacturing techniques such ...
People present themselves in ways that counteract prejudices toward their group
2013-04-17
Individuals from stigmatized groups choose to present themselves in ways that counteract the specific stereotypes and prejudices associated with their group, according to a new study published in Psychological Science, a journal of the Association for Psychological Science.
"People often think of prejudice as a simple, single phenomenon — general dislike for members of other groups — but recent research suggests that there are actually multiple, distinct types of prejudice," says graduate student Rebecca Neel, who conducted the research with her advisor Steven Neuberg ...
Few breast cancer survivors maintain adequate physical activity despite benefits
2013-04-17
SEATTLE – Breast cancer survivors are among the women who could most benefit from regular physical activity, yet few meet national exercise recommendations during the 10 years after being diagnosed, according to a study by researchers at Fred Hutchinson Cancer Research Center. Prior studies and available evidence show a strong association between physical activity and reduced mortality, extended survival and higher quality of life among breast cancer survivors. With 2.9 million breast cancer survivors living in the U.S. and another 80,000 added annually, there is considerable ...
Reproductive tract secretions elicit ovulation
2013-04-17
Baltimore, MD— Eggs take a long time to produce in the ovary, and thus are one of a body's precious resources. It has been theorized that the body has mechanisms to help the ovary ensure that ovulated eggs enter the reproductive tract at the right time in order to maximize the chance of successful fertilization.
New research from Carnegie's Allan Spradling and Jianjun Sun has shed light on how successful ovulation and fertilization are brought about by studying these processes in fruit flies. They found that secretions from special glands within the fruit fly's reproductive ...
Not everyone likes the company picnic
2013-04-17
COLUMBUS, Ohio – The workers who may have the most to gain from attending company social events may be the ones who actually get the least value from them, a new study suggests.
Researchers found that, in general, workers tended to report closer relationships with their colleagues the more that they attended company social events and shared their nonwork lives with their co-workers.
But that positive association between workplace sharing and closer relationships didn't occur for workers who were racially dissimilar from their colleagues – for example, the only black ...
Is your migraine preventive treatment balanced between drugs' benefits and harms?
2013-04-17
Migraine headaches are a major cause of ill health and a reduced quality of life. Some individuals suffer from a frequent and severe migraine problem which means that they require regular medication to try and prevent them. A new review¹ of the medications, which may help to prevent episodic migraines, appears in the Journal of General Internal Medicine², published by Springer. The authors, Tatyana Shamliyan from the University of Minnesota School of Public Health, and her colleagues, compare published research on the drugs available to find those which offer the best ...
Patients who have STEMI heart attacks while hospitalized more likely to die
2013-04-17
CHAPEL HILL, N.C. – If you suffer a heart attack while walking down the street and are taken to the hospital quickly, your chances of survival are very good. But if you have a heart attack while already in the hospital for something else, you are 10 times more likely to die.
That surprising finding comes from a study by University of North Carolina School of Medicine researchers. Their study, which is the first to systematically examine outcomes among hospital inpatients who suffer a type of heart attack called an ST elevation myocardial infarction (STEMI), was published ...
Mindfulness therapy might help veterans with combat-related post-traumatic stress disorder
2013-04-17
ANN ARBOR, Mich. — Mindfulness exercises that include meditation, stretching, and acceptance of thoughts and emotions might help veterans with combat-related post-traumatic stress disorder find relief from their symptoms.
A new collaborative study from the University of Michigan Health System and the VA Ann Arbor Healthcare System shows that veterans with PTSD who completed an 8-week mindfulness-based group treatment plan showed a significant reduction in symptoms as compared to patients who underwent treatment as normal.
Mindfulness-based cognitive therapy, or MBCT, ...
Children and teens with autism more likely to become preoccupied with video games
2013-04-17
COLUMBIA, Mo. – Children and teens with autism spectrum disorder (ASD) use screen-based media, such as television and video games, more often than their typically developing peers and are more likely to develop problematic video game habits, a University of Missouri researcher found.
"Many parents and clinicians have noticed that children with ASD are fascinated with technology, and the results of our recent studies certainly support this idea," said Micah Mazurek, an assistant professor of health psychology and a clinical child psychologist at MU. "We found that children ...
Improved molecular tools streamline influenza testing and management
2013-04-17
Philadelphia, PA, April 17, 2013 – Over 40,000 people die each year in the United States from influenza-related diseases. In patients whose immune systems are compromised, antiviral therapy may be life-saving, but it needs to be initiated quickly. It is therefore crucial to diagnose and type the influenza rapidly. Scientists in the Netherlands have designed and evaluated a set of molecular assays that they say are a sensitive and good alternative for conventional diagnostic methods and can produce results in one day without the need for additional equipment. The results ...